{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:15:26Z","timestamp":1771002926808,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.05.080","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T08:43:59Z","timestamp":1213778639000},"page":"4563-4570","source":"Crossref","is-referenced-by-count":16,"title":["Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines"],"prefix":"10.1016","volume":"26","author":[{"given":"Roman","family":"Prymula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Chlibek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Splino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kaliskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Lommel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1016\/j.vaccine.2008.05.080_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1081-1206(10)61660-2","article-title":"Immunization issues for the 21st century","volume":"90","author":"Frenkel","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7397","key":"10.1016\/j.vaccine.2008.05.080_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.326.7397.995","article-title":"Safety and efficacy of combination vaccines","volume":"326","author":"Elliman","year":"2003","journal-title":"BMJ"},{"issue":"RR-5","key":"10.1016\/j.vaccine.2008.05.080_bib3","first-page":"1","article-title":"Combination vaccines for childhood immunization","volume":"48","author":"Modlin","year":"1999","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.080_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1469-0691.2002.00424.x","article-title":"The new pneumococcal vaccine","volume":"8","author":"Obaro","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2008.05.080_bib5","unstructured":"Meyerhoff A, Greenberg D, Jacobs RJ. Effects of a new combination vaccine on childhood immunization coverage rates. www.cdc.confex.com\/cdc\/nic2004\/techprogram\/paper 5233.htm. Accessed on 10 October 2006."},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.080_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.vaccine.2006.08.038","article-title":"Response and persistence of antibodies to PRP-T and DTwP vaccines with concomitant administration of conjugate vaccines","volume":"25","author":"Ocampo","year":"2007","journal-title":"Vaccine"},{"issue":"9512","key":"10.1016\/j.vaccine.2008.05.080_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.080_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/00006454-200011000-00004","article-title":"Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody","volume":"19","author":"Dagan","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.080_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.080_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.080_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/01.inf.0000143640.03214.18","article-title":"Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants","volume":"23","author":"Nurkka","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.080_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.080_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/mpd.2000.107796","article-title":"Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections","volume":"137","author":"Schmitt","year":"2000","journal-title":"J Pediatr"},{"issue":"12","key":"10.1016\/j.vaccine.2008.05.080_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/01.inf.0000145427.19167.35","article-title":"Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine","volume":"23","author":"Tejedor","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.080_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"25","key":"10.1016\/j.vaccine.2008.05.080_bib16","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.vaccine.2005.01.087","article-title":"Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age","volume":"23","author":"Tichmann","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.080_bib17","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.vaccine.2003.11.044","article-title":"Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants","volume":"22","author":"Zepp","year":"2004","journal-title":"Vaccine"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2008.05.080_bib18","first-page":"2726","article-title":"Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid","volume":"17","author":"Ahman","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.080_bib19","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.080_bib20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00006454-199711000-00010","article-title":"Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.080_bib21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1001\/jama.293.14.1751","article-title":"Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial","volume":"293","author":"Buttery","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.080_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpeds.2007.02.013","article-title":"Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine","volume":"151","author":"Pichichero","year":"2007","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.080_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.080_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00006454-200208000-00006","article-title":"Hepatitis A booster vaccine in children after infant immunization","volume":"21","author":"Kanra","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.080_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0264-410X(98)00237-0","article-title":"Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme","volume":"17","author":"Piazza","year":"1999","journal-title":"Vaccine"},{"issue":"RR-12","key":"10.1016\/j.vaccine.2008.05.080_bib26","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.080_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.inf.0000207409.92198.6f","volume":"25","author":"Black","year":"2006","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:56:14Z","timestamp":1684443374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08007068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":27,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0264410X08007068"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}